
QIAGEN N.V. QGEN
QIAGEN N.V. Historical Prices | QGEN
Annual Historical Prices QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 38.3 | 44 | 43.1 | 49.7 | 50 | 35.9 | 38.4 | 33.7 | 27.4 | 21.1 | 25.3 | 22.2 | 21.4 | 15.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50 | 15.3 | 33.3 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Syneos Health
SYNH
|
90.6 | - | - | $ 4.46 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Renalytix AI plc
RNLX
|
0.21 | - | 5.66 % | $ 22.7 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Psychemedics Corporation
PMD
|
2.93 | - | -1.84 % | $ 15.3 M | ||
|
Quotient Limited
QTNT
|
2.59 | - | -11.32 % | $ 1.1 M | ||
|
T2 Biosystems
TTOO
|
2.98 | - | -39.35 % | $ 313 K | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
Bioventus
BVS
|
9.12 | $ 13.0 | 1.39 % | $ 866 M | ||
|
DarioHealth Corp.
DRIO
|
8.24 | $ 6.75 | 2.31 % | $ 26.9 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.69 | 1.45 % | $ 87.3 K | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Biodesix
BDSX
|
14.9 | $ 27.7 | 1.09 % | $ 209 M | ||
|
BioNano Genomics
BNGO
|
1.46 | $ 1.56 | 17.29 % | $ 8.49 M | ||
|
Burning Rock Biotech Limited
BNR
|
3.11 | $ 11.68 | 0.69 % | $ 123 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 52.64 | 0.52 % | $ 2.81 B | ||
|
Celcuity
CELC
|
115 | $ 82.7 | 0.1 % | $ 3.87 B | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 1.14 | 2.7 % | $ 1.52 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 272.88 | 0.59 % | $ 13.5 B | ||
|
Castle Biosciences
CSTL
|
16.3 | $ 35.5 | 6.16 % | $ 1.03 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 247.08 | 3.9 % | $ 27.4 B | ||
|
Meridian Bioscience
VIVO
|
31.8 | - | - | $ 1.49 B | ||
|
Biomerica
BMRA
|
2.09 | $ 2.3 | 0.42 % | $ 6.7 M | ||
|
Fulgent Genetics
FLGT
|
17.1 | $ 21.28 | 3.05 % | $ 655 M | ||
|
Guardant Health
GH
|
107 | $ 175.65 | 4.65 % | $ 22 B | ||
|
ICON Public Limited Company
ICLR
|
129 | $ 172.45 | 2.08 % | $ 13.5 B | ||
|
IDEXX Laboratories
IDXX
|
636 | $ 510.73 | 0.23 % | $ 41.1 B | ||
|
Danaher Corporation
DHR
|
210 | $ 209.36 | 3.01 % | $ 149 B | ||
|
Illumina
ILMN
|
163 | $ 222.29 | 6.76 % | $ 34.5 B | ||
|
IQVIA Holdings
IQV
|
165 | $ 269.67 | 1.51 % | $ 46.4 B | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 13.46 | 0.14 % | $ 457 M | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 323.97 | 2.75 % | $ 27 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 100.73 | 0.41 % | $ 6.8 B | ||
|
DexCom
DXCM
|
65.4 | $ 86.45 | 2.09 % | $ 33.7 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 620.48 | 4.21 % | $ 17.9 B | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 330.4 | 3.47 % | $ 27.4 B | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 3.88 | 2.37 % | $ 359 M | ||
|
ENDRA Life Sciences
NDRA
|
4.65 | $ 5.66 | 1.13 % | $ 4.45 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 18.89 | 2.61 % | $ 2.42 B | ||
|
Neogen Corporation
NEOG
|
11.5 | $ 12.25 | 2.51 % | $ 2.66 B | ||
|
National Research Corporation
NRC
|
14.1 | $ 21.96 | 5.63 % | $ 492 M | ||
|
Natera
NTRA
|
223 | $ 350.78 | 2.63 % | $ 48 B | ||
|
OPKO Health
OPK
|
1.38 | $ 1.57 | 0.64 % | $ 1.18 B | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.34 | 0.37 % | $ 402 M | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 24.9 | 1.99 % | $ 23.6 B | ||
|
Personalis
PSNL
|
4.83 | $ 16.1 | 0.31 % | $ 1.44 B |